Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated May 07, 2026, titled "Press Release on Q-4 Financials".
VIJAYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Vijaya Diagnostic Centre reported strong Q4 FY26 results with highest-ever quarterly revenue of Rs 219.3 Cr, up 26.6% YoY. Full year FY26 revenue crossed Rs 800 Cr mark at Rs 814.2 Cr, growing 19.5% YoY. EBITDA grew 38.7% YoY in Q4 to Rs 95.5 Cr with margins expanding 379 basis points to 43.5%. PAT grew 37.5% YoY to Rs 47.9 Cr in Q4, while FY26 PAT stood at Rs 173 Cr, up 20.3%. Total tests processed grew 18.5% YoY to 4.49 Mn in Q4, with average realization per test increasing 6.8% to Rs 488. The company achieved 16.5% CAGR over five years since listing, outperforming its 15% guidance.
Strong quarterly and annual performance with margin expansion indicates operational efficiency gains. Revenue crossing Rs 800 Cr milestone and robust PAT growth signal solid execution, likely positive for the stock.